Cue Health Inc. HLTH
We take great care to ensure that the data presented and summarized in this overview for Cue Health Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HLTH
View all-
Decheng Capital Management Iii (Cayman), LLC8.98MShares$02.19% of portfolio
-
ETF Managers Group, LLC Summit, NJ49.1KShares$00.0% of portfolio
-
Executive Wealth Group LLC Kirkland, WA42.2KShares$00.0% of portfolio
-
Alphabet Inc. Mountain View, CA27KShares$00.0% of portfolio
-
Front Barnett Associates LLC Chicago, IL25.4KShares$00.0% of portfolio
-
Ifp Advisors, Inc1KShares$00.0% of portfolio
-
Old Point Trust & Financial Services N A350Shares$00.0% of portfolio
-
Baystate Wealth Management LLC200Shares$00.0% of portfolio
Latest Institutional Activity in HLTH
Top Purchases
Top Sells
About HLTH
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Insider Transactions at HLTH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 27
2024
|
Tarsadia Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,319,000
-100.0%
|
-
|
|
Aug 23
2024
|
Tarsadia Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,298,453
-99.98%
|
-
|
|
Aug 23
2024
|
Tarsadia Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,684,791
-100.0%
|
-
|
|
Mar 25
2024
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,456
-0.46%
|
$0
$0.19 P/Share
|
|
Mar 05
2024
|
Christopher K Achar Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,482
-0.52%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Randall E. Pollard Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,304
-1.43%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,742
-0.09%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,604
-0.29%
|
$0
$0.25 P/Share
|
|
Mar 05
2024
|
Aasim Javed Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,327
-1.3%
|
$0
$0.25 P/Share
|
|
Feb 16
2024
|
Rishi Reddy Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,300
+46.59%
|
-
|
|
Feb 08
2024
|
Christopher K Achar Director |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+15.58%
|
-
|
|
Feb 08
2024
|
Randall E. Pollard Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+28.15%
|
-
|
|
Feb 08
2024
|
Ayub K Khattak President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
700,000
+5.28%
|
-
|
|
Feb 08
2024
|
Clint Sever Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+10.18%
|
-
|
|
Feb 08
2024
|
Aasim Javed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+21.93%
|
-
|
|
Dec 26
2023
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,781
-0.65%
|
$0
$0.3 P/Share
|
|
Dec 26
2023
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,938
-0.27%
|
$0
$0.3 P/Share
|
|
Dec 05
2023
|
Erica Palsis General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-0.76%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Randall E. Pollard Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,186
-1.95%
|
$0
$0.35 P/Share
|
|
Dec 05
2023
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,885
-0.4%
|
$0
$0.35 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.26M shares |
|---|
| Payment of exercise price or tax liability | 131K shares |
|---|---|
| Open market or private sale | 18.3M shares |